<html>
<head>PUBMED IDs for hPMC2</head>
<body bgcolor='#C5F0F2'><h1>hPMC2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/10908561/'>Identification and characterization of a novel factor that regulates quinone reductase gene transcriptional activity.</a> July 26  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/18663360/'>hPMC2 is required for recruiting an ERbeta coactivator complex to mediate transcriptional upregulation of NQO1 and protection against oxidative DNA damage by tamoxifen.</a> July 30  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/21602889/'>The exonuclease activity of hPMC2 is required for transcriptional regulation of the QR gene and repair of estrogen-induced abasic sites.</a> January 14  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/23795205/'>TARGETING THE GENOTOXIC EFFECTS OF ESTROGENS.</a> June 25  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23794732/'>Effective activity of cytokine-induced killer cells against autologous metastatic melanoma including cells with stemness features.</a> April 2  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25849309/'>Downregulation of hPMC2 imparts chemotherapeutic sensitivity to alkylating agents in breast cancer cells.</a> January 21  2015<br></body></html>
